Express News | Pasithea Therapeutics Corp - Src Recommends Escalation to 15Mg Dose Level

BreakingsNov 20 20:02

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation From Its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

GlobeNewswireNov 20 20:02

Express News | Pasithea Therapeutics Announces Positive Safety Review Committee (Src) Recommendation From Its Ongoing Phase 1 Clinical Trial of Pas-004 in Advanced Cancer

BreakingsNov 20 20:02

10-Q: Q3 2024 Earnings Report

SECNov 14 05:37 · Announcements

Pasithea Therapeutics Files to Sell 3.74M Shares of Common Stock for Holders

Seeking AlphaOct 8 04:52

Pasithea Therapeutics Priced $5M Private Placement of $1.2M Shares At $4.10/Share to Advance Next-Gen Cancer Treatments

BenzingaSep 27 15:03